...
首页> 外文期刊>Thoracic cancer. >Hsa_circRNA _0000518 facilitates breast cancer development via regulation of the miR ‐326/ FGFR1 axis
【24h】

Hsa_circRNA _0000518 facilitates breast cancer development via regulation of the miR ‐326/ FGFR1 axis

机译:HSA_CIRCRNA _0000518通过MIR -326 / FGFR1轴的调节促进乳腺癌发育

获取原文

摘要

BACKGROUND:Breast cancer (BC) is a heterogeneous malignant tumor that threatens the health of women worldwide. Hsa_circRNA_0000518 (circ_0000518) has been revealed to be upregulated in BC tissues. However, the role and mechanism of circ_0000518 in BC are indistinct.METHODS:Quantitative real-time polymerase chain reaction (qRT-PCR) was implemented to detect the levels of circ_0000518, microRNA (miR)-326, and fibroblast growth factor receptor 1 (FGFR1) mRNA in BC tissues and cells. Cell counting kit-8 (CCK-8), colony formation, flow cytometry, and transwell assays were executed to estimate BC cell proliferation, cell cycle progression, apoptosis, migration, and invasion. The relationship between circ_0000518 or FGFR1 and miR-326 was verified by dual-luciferase reporter and/or RNA immunoprecipitation (RIP) assays. The role of circ_0000518 in vivo was confirmed by xenograft assay.RESULTS:Circ_0000518 and FGFR1 were upregulated while miR-326 was downregulated in BC tissues and cells. Circ_0000518 silencing impeded tumor growth in vivo and induced cell cycle arrest, apoptosis, cured proliferation, colony formation, migration, and invasion of BC cells in vitro. Circ_0000518 regulated FGFR1 expression via competitively binding to miR-326 in BC cells. MiR-326 inhibitor reversed the inhibitory influence of circ_0000518 knockdown on the malignant behaviors of BC cells. FGFR1 overexpression abolished miR-326 mimic-mediated influence on the malignant behaviors of BC cells.CONCLUSIONS:Circ_0000518 facilitated BC development via regulation of the miR-326/FGFR1 axis, suggesting that circ_0000518 might be a promising target for BC treatment.? 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
机译:背景:乳腺癌(BC)是一种异质性恶性肿瘤,全球威胁妇女的健康。 Hsa_circRNA_0000518(circ_0000518)已经揭示在BC组织中被上调。然而,在BC的作用和circ_0000518的机制是indistinct.METHODS:定量实时聚合酶链式反应(qRT-PCR)中的溶液中实现,以检测circ_0000518,微小RNA(MIR)-326,和成纤维细胞生长因子受体1的水平( FGFR1)的mRNA在BC组织和细胞。细胞计数试剂盒-8(CCK-8),集落形成,流式细胞术和Transwell检测被执行以估计BC细胞增殖,细胞周期进程,细胞凋亡,迁移和侵袭。 circ_0000518或FGFR1和miR-326之间的关系是由双荧光素酶报告和/或RNA免疫沉淀(RIP)测定法验证。的circ_0000518体内的作用证实了异种移植assay.RESULTS:Circ_0000518和FGFR1被上调,而的miR-326在BC组织和细胞中下调。 Circ_0000518沉默透水体内肿瘤生长和诱导的细胞周期停滞,细胞凋亡,增殖固化,集落形成,迁移和BC细胞的体外侵袭。 Circ_0000518经由BC细胞竞争性结合的miR-326调节的FGFR1的表达。 MIR-326抑制剂逆转对BC细胞的恶性行为circ_0000518敲低的抑制的影响。 FGFR1表达取消了对BC cells.CONCLUSIONS的恶性行为的miR-326模拟介导的影响:Circ_0000518通过的miR-326 / FGFR1轴的调节促进BC的发展,这表明circ_0000518可能是公元前治疗新靶点。? 2020作者。中国肺部肿瘤集团和约翰瓦里和儿子澳大利亚发表的胸癌

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号